Veeva Announces Share Repurchase Program

Rhea-AI Summary

Veeva (NYSE: VEEV) announced on Jan. 5, 2026 that its board approved a share repurchase program authorizing up to $2.0 billion of Class A common stock purchases.

The program may use open-market purchases, privately negotiated transactions, or Rule 10b5-1 trading plans and will comply with Rule 10b-18 and other applicable laws. The program term is 2 years, repurchases are at management discretion, and Veeva is not obligated to buy any specific number of shares; the program may be suspended or cancelled at any time.

Positive

• $2.0 billion repurchase authorization
• Program term: 2 years
• Permits open-market and negotiated purchases

Negative

• No obligation to purchase a specific number of shares
• Repurchases subject to management discretion and market conditions
• Program may be cancelled or suspended at any time

Key Figures

Buyback authorization $2 billion Maximum Class A share repurchases under new program

Program term 2 years Duration of authorized share repurchase program

Market Reality Check

$240.12 Last Close

Volume Volume 1,556,571 vs 20-day average 1,583,905 indicates typical trading activity ahead of the buyback news. normal

Technical Shares at $221.32 are trading below the 200-day MA of $263.59, well under the 52-week high of $310.50.

Peers on Argus

VEEV was down 1.68% while key peers like DOCS (+5.06%), GEHC (+2.72%), HQY (+2.76%), TEM (+0.68%), and WAY (+1.47%) showed gains, suggesting company-specific dynamics before the buyback announcement.

Historical Context

Date	Event	Sentiment	Move	Catalyst
Dec 04	Investor conference	Positive	-0.1%	Upcoming presentation at Raymond James 2025 TMT and Consumer Conference.
Dec 03	Product/AI launch	Positive	+0.5%	Launch of Veeva AI Agents for Vault CRM and PromoMats.
Nov 24	Partnership expansion	Positive	-3.4%	Roche expanding use of Veeva Vault CRM and Veeva AI capabilities.
Nov 20	Earnings results	Positive	-0.9%	Strong fiscal 2026 Q3 growth in revenue, income, and AI and cloud progress.
Nov 04	Customer adoption	Positive	+0.3%	More than 100 emerging biotechs adopting Veeva Basics across operations.

Pattern Detected

Recent positive corporate updates, including product launches, partnerships, and strong quarterly results, often saw muted or negative next-day price reactions, indicating a pattern of cautious trading around good news.

Recent Company History

Over the last few months, Veeva reported solid fundamental and strategic progress. Fiscal 2026 Q3 results on Nov 20, 2025 showed double-digit growth in revenue and profitability. Earlier, Veeva expanded its partnership with Roche and launched Veeva AI Agents to deepen its AI footprint. Additional news highlighted adoption of Veeva Basics by more than 100 emerging biotechs and ongoing investor conference participation. Against this backdrop of growth and product momentum, today’s $2 billion share repurchase authorization adds a capital return dimension to the story.

Market Pulse Summary

This announcement introduces a first-time share repurchase program authorizing up to $2 billion of Class A common stock over 2 years, adding a capital return lever alongside Veeva’s growth investments. The move follows periods of product expansion, partnerships, and solid financial performance. Investors may focus on how actively management uses the authorization, the balance between buybacks and continued investment in AI and cloud offerings, and any related updates in future earnings or regulatory filings.

Key Terms

share repurchase program financial

"its Board of Directors approved a share repurchase program with authorization"

A share repurchase program is when a company buys back its own shares from the marketplace. This reduces the total number of shares available, which can increase the value of each remaining share and signal confidence in the company's prospects. For investors, it often suggests that the company believes its stock is undervalued or that it has extra cash to return to shareholders.

rule 10b5-1 regulatory

"including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

rule 10b-18 regulatory

"including Rule 10b-18 under the Exchange Act"

Rule 10b-18 is a regulation that sets strict rules for how a company's executives and employees can buy back their own company's stock from the market. It helps ensure that these buybacks happen in a fair and transparent way, reducing the chance of market manipulation. This is important for investors because it offers protection against unfair practices and promotes confidence in the integrity of the stock market.

AI-generated analysis. Not financial advice.

PLEASANTON, Calif., Jan. 5, 2026 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced that its Board of Directors approved a share repurchase program with authorization to purchase up to $2 billion of shares of its Class A common stock.

"The breadth of our multi-product business, paired with a focus on operational discipline, innovation, and customer success, continues to drive financial outperformance and robust cash generation. This strength provides Veeva the healthy balance sheet to invest in the significant opportunities ahead and to return capital to shareholders," said chief financial officer Brian Van Wagener. "These ongoing investments in product excellence and the launch of our first ever share repurchase program reflect the confidence we have in our long-term growth trajectory and the enduring value we can deliver across the life sciences industry."

Under the program, Veeva may repurchase shares from time to time through open market purchases, in privately negotiated transactions, or by other means, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), in accordance with applicable securities laws and other restrictions, including Rule 10b-18 under the Exchange Act. The timing and total amount of any stock repurchases will be determined at management's discretion and depend upon business, economic and market conditions, corporate and regulatory requirements, prevailing stock prices, and other considerations. The share repurchase program has a term of 2 years, does not obligate Veeva to acquire a specific number of shares of Class A common stock, and may be canceled or suspended at any time without notice.

About Veeva Systems

Veeva delivers the industry cloud for life sciences with software, data, and business consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders and the industries it serves. For more information, visit veeva.com.

Forward-Looking Statements

This release contains forward-looking statements regarding Veeva's intended share repurchases. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended October 31, 2025, which you can find here (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov.

Investor Relations Contact:		Media Contact:
Gunnar Hansen		Maria Scurry
Veeva Systems Inc.		Veeva Systems Inc.
267-460-5839		781-366-7617
ir@veeva.com		pr@veeva.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/veeva-announces-share-repurchase-program-302653096.html

SOURCE Veeva Systems

FAQ

What did Veeva (VEEV) announce on January 5, 2026?

Veeva announced a board-approved share repurchase program authorizing up to $2.0 billion of Class A common stock over a 2-year term.

How will Veeva (VEEV) execute the $2 billion buyback?

Veeva may buy shares via open-market purchases, privately negotiated transactions, or Rule 10b5-1 trading plans, in compliance with Rule 10b-18.

Does the Veeva (VEEV) repurchase program guarantee a specific amount of shares?

No; the program does not obligate Veeva to acquire any specific number of shares and purchases are at management discretion.

What is the duration of Veeva's (VEEV) repurchase program?

The share repurchase program has a 2-year term beginning from the announcement date.

Can Veeva (VEEV) stop the repurchase program early?

Yes; the company may cancel or suspend the program at any time without notice.

What factors will determine timing and amount of Veeva (VEEV) repurchases?

Timing and amounts depend on business, economic and market conditions, regulatory requirements, prevailing stock prices, and other considerations.